Viewing Study NCT04634435


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2025-12-31 @ 4:43 AM
Study NCT ID: NCT04634435
Status: COMPLETED
Last Update Posted: 2025-01-20
First Post: 2020-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Autologous Memory-like NK Cell Therapy With BHV-1100 and Low Dose IL-2 in Multiple Myeloma Patients
Sponsor: Biohaven Pharmaceuticals, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: BHV1100-101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View